CVE-2025-61940
Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication
Using EC2 Software NMIS BioDose by Mirion Medical?
Get instant alerts when new vulnerabilities affect EC2 Software NMIS BioDose - before attackers find them.
Description
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Affected
Our own answer: ranges merged, affected separated from platform-only, with confidence and review flags.
Remediation
No guide yetNo remediation guidance has been written for this CVE yet, and no fixed version or vendor advisory is recorded against it.
References (1)
SSVC — Action Prioritization
SSVC signals action urgency (what to patch first), separate from CVSS which measures severity.
CVSS
- Attack Vector
- NETWORK
- Complexity
- LOW
- Privileges
- LOW
- User Interaction
- NONE
- Scope
- UNCHANGED
- Confidentiality
- HIGH
- Integrity
- HIGH
- Availability
- HIGH
Quick Info
Get alerted
Stop reading CVE feeds looking for your own stack
Track the products you run and VulnTracker tells you when a new CVE affects them — with what is known about fixing it, and nothing about the rest.